Related Experiment Video
Updated: Oct 3, 2025

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies
Erica Pranzini1, Giovanni Raugei1, Maria Letizia Taddei2
1Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Abstract:
Tumor relapse represents one of the main obstacles to cancer treatment. Many patients experience cancer relapse even decades from the primary tumor eradication, developing more aggressive and metastatic disease. This phenomenon is associated with the emergence of dormant cancer cells, characterized by cell cycle arrest and largely insensitive to conventional anti-cancer therapies. These rare and elusive cells may regain proliferative abilities upon the induction of cell-intrinsic and extrinsic factors, thus fueling tumor re-growth and metastasis formation. The molecular mechanisms underlying the maintenance of resistant dormant cells and their awakening are intriguing but, currently, still largely unknown. However, increasing evidence recently underlined a strong dependency of cell cycle progression to metabolic adaptations of cancer cells. Even if dormant cells are frequently characterized by a general metabolic slowdown and an increased ability to cope with oxidative stress, different factors, such as extracellular matrix composition, stromal cells influence, and nutrient availability, may dictate specific changes in dormant cells, finally resulting in tumor relapse. The main topic of this review is deciphering the role of the metabolic pathways involved in tumor cells dormancy to provide new strategies for selectively targeting these cells to prevent fatal recurrence and maximize therapeutic benefit.
Insights
Tumor relapse is driven by dormant cancer cells that resist treatment. Understanding their metabolic pathways is key to developing new therapies that target these cells and prevent cancer recurrence.
Area of Science:
- Oncology
- Cancer Biology
- Metabolism
Background:
- Tumor relapse, often decades after initial treatment, poses a major challenge in cancer care.
- This recurrence is frequently linked to dormant cancer cells that are resistant to conventional therapies.
- These dormant cells can reactivate, leading to tumor regrowth and metastasis.
Purpose of the Study:
- To explore the molecular mechanisms behind cancer cell dormancy and reactivation.
- To investigate the critical role of metabolic pathways in maintaining dormant cancer cells.
- To identify novel therapeutic strategies targeting metabolic adaptations in dormant cells to prevent relapse.
Main Methods:
- Review of current literature on cancer dormancy, cell cycle regulation, and metabolic adaptations.
- Analysis of factors influencing dormant cell survival and reactivation, including microenvironmental cues.
- Exploration of metabolic pathways essential for dormant cancer cell maintenance.
Main Results:
- Dormant cancer cells exhibit cell cycle arrest and resistance to standard treatments.
- Metabolic adaptations are crucial for the survival and persistence of dormant cancer cells.
- Specific microenvironmental factors can trigger the awakening of dormant cells, leading to relapse.
Conclusions:
- Targeting metabolic pathways in dormant cancer cells offers a promising strategy to prevent tumor recurrence.
- Further research into the metabolic dependencies of dormant cells is needed to develop effective therapies.
- Understanding dormancy metabolism can improve patient outcomes and maximize therapeutic benefits.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
12:48A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
Published on: February 16, 2018
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers
Tumor Immunotherapy
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...